Nerve Growth Factor (NGF) and its receptors TrkA and p75 are expressed in physiological states in the anterior and posterior segments of the human eye, where they exert several tissue-specific functions. The roles played by NGF in the homeostasis of the eye and in vision are, therefore, crucial and have been widely investigated both in vitro and in vivo, with growing evidence of an NGF-pathway alteration in several ocular diseases. In this review we describe the functions of NGF in health and diseases states of the eye, and discuss the potential therapeutic effectiveness of NGF in preliminary clinical reports performed in severe ocular diseases unresponsive to any standard treatment. In fact, pharmacodynamic studies showing that NGF administered topically on the ocular surface affects not only the ocular surface but is also able to reach the retina, optic nerve and brain, recently opened new perspectives for the treatment of challenging ocular surface diseases, optic nerve diseases, and degenerative diseases of the retina currently lacking an effective therapy.

Clinical applications of NGF in ocular diseases / Lambiase, Alessandro; Mantelli, Flavio; Sacchetti, Marta; Rossi, Simona; Aloe, Luigi; Bonini, Stefano. - In: ARCHIVES ITALIENNES DE BIOLOGIE. - ISSN 0003-9829. - STAMPA. - 149:2(2011), pp. 283-292.

Clinical applications of NGF in ocular diseases

LAMBIASE, ALESSANDRO;SACCHETTI, MARTA;
2011

Abstract

Nerve Growth Factor (NGF) and its receptors TrkA and p75 are expressed in physiological states in the anterior and posterior segments of the human eye, where they exert several tissue-specific functions. The roles played by NGF in the homeostasis of the eye and in vision are, therefore, crucial and have been widely investigated both in vitro and in vivo, with growing evidence of an NGF-pathway alteration in several ocular diseases. In this review we describe the functions of NGF in health and diseases states of the eye, and discuss the potential therapeutic effectiveness of NGF in preliminary clinical reports performed in severe ocular diseases unresponsive to any standard treatment. In fact, pharmacodynamic studies showing that NGF administered topically on the ocular surface affects not only the ocular surface but is also able to reach the retina, optic nerve and brain, recently opened new perspectives for the treatment of challenging ocular surface diseases, optic nerve diseases, and degenerative diseases of the retina currently lacking an effective therapy.
2011
Administration, Ophthalmic; Eye Diseases; Humans; Nerve Growth Factor
01 Pubblicazione su rivista::01a Articolo in rivista
Clinical applications of NGF in ocular diseases / Lambiase, Alessandro; Mantelli, Flavio; Sacchetti, Marta; Rossi, Simona; Aloe, Luigi; Bonini, Stefano. - In: ARCHIVES ITALIENNES DE BIOLOGIE. - ISSN 0003-9829. - STAMPA. - 149:2(2011), pp. 283-292.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/807409
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 56
  • ???jsp.display-item.citation.isi??? 54
social impact